Massachusetts Financial Services
CHRS icon

Massachusetts Financial Services’s Coherus Oncology CHRS Stock Holding History

Massachusetts Financial Services’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-99,111
Closed -$103K – 884
2024
Q3 		$103K Sell
99,111
-2,400
-2% -$3.29K ﹤0.01% 845
2024
Q2 		$176K Buy
101,511
+3,409
+3% +$6.86K ﹤0.01% 855
2024
Q1 		$234K Sell
98,102
-216
-0.2% -$532 ﹤0.01% 830
2023
Q4 		$327K Sell
98,318
-3,104
-3% -$8.31K ﹤0.01% 816
2023
Q3 		$379K Sell
101,422
-3,887
-4% -$18K ﹤0.01% 818
2023
Q2 		$450K Sell
105,309
-2,479
-2% -$14.6K ﹤0.01% 795
2023
Q1 		$737K Sell
107,788
-3,047
-3% -$23.6K ﹤0.01% 785
2022
Q4 		$878K Buy
110,835
+2,347
+2% +$18.1K ﹤0.01% 785
2022
Q3 		$1.04M Sell
108,488
-988
-0.9% -$10K ﹤0.01% 779
2022
Q2 		$793K Buy
109,476
+552
+0.5% +$4.8K ﹤0.01% 792
2022
Q1 		$1.41M Buy
108,924
+1,120
+1% +$14.2K ﹤0.01% 777
2021
Q4 		$1.72M Sell
107,804
-2,183
-2% -$38.2K ﹤0.01% 789
2021
Q3 		$1.77M Sell
109,987
-1,444
-1% -$21.2K ﹤0.01% 795
2021
Q2 		$1.54M Buy
111,431
+956
+0.9% +$13.5K ﹤0.01% 803
2021
Q1 		$1.61M Sell
110,475
-13,092
-11% -$222K ﹤0.01% 795
2020
Q4 		$2.15M Sell
123,567
-1,237
-1% -$22K ﹤0.01% 727
2020
Q3 		$2.29M Sell
124,804
-4,889
-4% -$91K ﹤0.01% 705
2020
Q2 		$2.32M Sell
129,693
-3,306
-2% -$56K ﹤0.01% 677
2020
Q1 		$2.16M Buy
132,999
+21,050
+19% +$389K ﹤0.01% 675
2019
Q4 		$2.02M Buy
111,949
+94,733
+550% +$1.75M ﹤0.01% 709
2019
Q3 		$349K Buy
+17,216
New +$344K ﹤0.01% 808

Other funds holding CHRS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Massachusetts Financial Services's CHRS Position: Q4 2024 in Review

Massachusetts Financial Services sold out of Coherus Oncology (CHRS) in Q4 2024, closing a stake of 99,111 shares — an estimated $103K sold.

Massachusetts Financial Services first reported a position in CHRS in Q3 2019 and held it in 21 quarters. The position peaked at $2.32M in Q2 2020. 124 funds tracked by Wall St. Rank hold CHRS as of Q4 2024.

  • Massachusetts Financial Services reported no remaining Coherus Oncology position as of Q4 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 99,111 Coherus Oncology shares in Q4 2024, an estimated $103K.
  • Massachusetts Financial Services first reported a position in Coherus Oncology in Q3 2019 and held it in 21 quarters.
  • Massachusetts Financial Services's Coherus Oncology position peaked at $2.32M in Q2 2020.
  • 124 funds tracked by Wall St. Rank held Coherus Oncology as of Q4 2024.

Based on Massachusetts Financial Services's 13F filing for Q4 2024, filed 12 Feb 2025.